Skip to content

Application of Intelligent Pharmaceutical Service Platform for the Treatment of Cancer Pain in outpatient

Application of Intelligent Pharmaceutical Service Platform for the Treatment of Cancer Pain in outpatient

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023075
Enrollment
Unknown
Registered
2019-05-10
Start date
2018-06-01
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

Experimental group:Clinical Pharmacy Service through the platform
Control Group:Usual care

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged>18 years old male and female; 2. Diagnosed malignant tumor by pathological method with pain,NRS>3; 3. Patients were prescribed or given opioids at enrollment; 4. Patients or their families are able to use mobile phone and wechat; 5. Education level is junior high school at least; 6. Patients or their families are willing to sign informed consent and complete follow-up forms.

Exclusion criteria

Exclusion criteria: 1) Patients' diagnosis of their disease are undefined; 2) Patients' main clinical data is incomplete; 3) Patients with incomplete return visit information. 4) Patients or their families refused to follow up or when the patient died.

Design outcomes

Primary

MeasureTime frame
Pain Intensity;

Secondary

MeasureTime frame
Use of Analgesic;Outcomes of BPI;Breakthrough Pain;Breakthrough Pain;Medication Adherence;Quality of life;Classification of PCNE;

Countries

China

Contacts

Public ContactJian Xiao

Department of Pharmacy, Xiangya Hospital, Central South University

admanoas@163.com+86 13973168895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026